Replimune Group REPL Increase (Decrease) in Research and Development Incentives Receivable
Increase (Decrease) in Research and Development Incentives Receivable at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept repl:IncreaseDecreaseInResearchAndDevelopmentIncentivesReceivable.
The official record: Replimune Group’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →
Ask your AI about Replimune Group's increase (decrease) in research and development incentives receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Replimune Group's increase (decrease) in research and development incentives receivable?
- Replimune Group (REPL) reported increase (decrease) in research and development incentives receivable of -$1.63M in Q2 2025.
- How has Replimune Group's increase (decrease) in research and development incentives receivable changed year-over-year?
- Replimune Group's increase (decrease) in research and development incentives receivable decreased by 473.2% year-over-year, from $437K to -$1.63M.
- What is the long-term trend for Replimune Group's increase (decrease) in research and development incentives receivable?
- Over 2 years (2022 to 2024), Replimune Group's increase (decrease) in research and development incentives receivable has grown at a 178.5% compound annual growth rate (CAGR), from $247K to $1.92M.
- What does increase (decrease) in research and development incentives receivable mean?
- This represents the change in receivables related to government grants, tax credits, or other incentives specifically tied to research and development activities. An increase indicates that the company has earned incentives that have not yet been collected in cash. It serves as a proxy for the company's ability to leverage external funding to offset high R&D costs.